<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A total of 935 patients with extranodal non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) diagnosed in the period between January 1985 and December 2000 in Kuwait <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center, serving the whole population of Kuwait, were used to describe the clinicopathological and epidemiological features of extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in Kuwait </plain></SENT>
<SENT sid="1" pm="."><plain>Extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> accounted for 45% of <z:hpo ids='HP_0000001'>all</z:hpo> NHL observed during this time </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> NHL cases from Kuwait <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> registry were analyzed and pathologically reclassified using the latest WHO (2000) classification </plain></SENT>
<SENT sid="3" pm="."><plain>The most common <z:hpo ids='HP_0002665'>lymphoma</z:hpo> observed was diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (58.60%) followed by Burkitt s <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) (3.80%) </plain></SENT>
<SENT sid="4" pm="."><plain>In the pediatric group, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> comprises more than two thirds of <z:hpo ids='HP_0000001'>all</z:hpo> patients (77.20%) </plain></SENT>
<SENT sid="5" pm="."><plain>The most common extranodal sites were stomach (19.70%) and skin (17.80%) in the adult group, large intestine (29.80%) and small intestine (19.30%) in the pediatric age group </plain></SENT>
<SENT sid="6" pm="."><plain>The majority (73.40%) of adult extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> was in stage IE-IIE and had a very good prognosis </plain></SENT>
<SENT sid="7" pm="."><plain>On the contrary, the majority of pediatric extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were found to be in stage III and IV </plain></SENT>
<SENT sid="8" pm="."><plain>Variations in treatment policies (single agent or combined chemotherapy, radiotherapy, combined modality treatment) adopted and changed during the time period of 16 years of this retrospective study were documented </plain></SENT>
</text></document>